O
Outlook Therapeutics, Inc. (OTLK)
NCM – Real Time Price. Currency in USD
1.10
-0.03 (-2.65%)
At close: Aug 12, 2026, 4:00 PM EDT
0.93
-0.17 (-15.31%)
After-hours: Aug 12, 2026, 6:02 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.10
-0.03 (-2.65%)
At close: Aug 12, 2026, 4:00 PM EDT
0.93
-0.17 (-15.31%)
After-hours: Aug 12, 2026, 6:02 PM EDT
No Data
There are no news for this stock.
Total debt $27.2M significantly exceeds cash reserves ($7.7M), raising financial stability concerns
Total current liabilities $38.9M surpass Total current assets $20.9M, signaling liquidity issues
Debt-to-equity ratio (-0.9) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$7.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.54 | 6.05 | 4.0 | |
| Quick ratio | 0.45 | 5.63 | 4.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 1.24 | 1.04 | 1.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 2.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 1M | 425K |
| Gross Profit | -205K | -44K | -114K | 657K | -313K |
| Operating Income | -63M | -53M | -72M | -67M | -56M |
| Net Income | -66M | -59M | -75M | -62M | -94M |
| EBITDA | -63M | -53M | -72M | -67M | -56M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -35.77 | 81.82 | 5.5 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | 102.88 | 73.56 | 10 |
| Next year | 1054.65 | 59.15 | 10 |
| Weighted average score | 6.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 110.55 | 80.69 | 27.27 | 47.6 | 10 |
| Y/Y | 999 | -125.62 | 82.02 | 28.62 | 7.8 |
| 3y average | 999 | 0.03 | 31.3 | -3.73 | 5.8 |
| 5y average | 999 | -14.99 | 26.17 | -17.26 | 5.5 |
| Weighted average score | 7.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |